JAMA Editor’s Summary

Rapid-Onset Opioid vs Neuromuscular Blocker for Rapid Sequence Intubation, 180-Day Outcomes in COVID-19 in REMAP-CAP, Recommendations for Antiretrovirals for Treatment and Prevention of HIV, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 3, 2023, issue. Related Content:

January 3, 2023

Listen on your favorite player Take me to this show’s page

Newer →

Catheter Ablation Techniques for Persistent Atrial Fibrillation, Medical Device Recalls, Review of Autism Spectrum Disorder, and more

← Older

Labor Unionization Among US Health Care Workers, Association of Family Income With Children’s Health, Review of Anxiety Disorders, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Rapid-Onset Opioid vs Neuromuscular Blocker for Rapid Sequence Intubation, 180-Day Outcomes in COVID-19 in REMAP-CAP, Recommendations for Antiretrovirals for Treatment and Prevention of HIV, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 3, 2023, issue. Related Content: